Item 9 Labs Corp.
OTC: INLB0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Jeffrey I. Rassas
- Employees
- 97
- Headquarters
- Phoenix, United States
- IPO year
- 2012
- Market cap
- $70.2K
- Website
- https://www.item9labscorp.com
Loading INLB…
Loading profile data…Frequently asked questions about INLB
What does Item 9 Labs Corp. (INLB) do?
Based in the United States, Item 9 Labs Corp. operates as a comprehensive cannabis company, encompassing both vertical integration in cannabis operations and the franchising of dispensaries. The firm produces a wide spectrum of cannabis and related goods, such as raw flower, various concentrates, distillates, and necessary hardware. These cannab...
Where does INLB trade?
Item 9 Labs Corp. (INLB) trades on the Other OTC.
What sector is INLB in?
Item 9 Labs Corp. (INLB) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Item 9 Labs Corp.?
Jeffrey I. Rassas is the chief executive officer of Item 9 Labs Corp. (INLB).
Where is Item 9 Labs Corp. headquartered?
Item 9 Labs Corp. is headquartered in United States.
Does INLB pay a dividend?
Item 9 Labs Corp. (INLB) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did INLB go public?
Item 9 Labs Corp. (INLB) completed its initial public offering in 2012.